Human Fibrinogen Market Research Report from 2023 forecast to 2029, by Manufacturers, Regions, Type and Application

The global Human Fibrinogen market size was valued at USD 818.8 million in 2022 and is forecast to a readjusted size of USD 2156.1 million by 2029 with a CAGR of 14.8% during review period.

Fibrinogen (factor I) is a glycoprotein in vertebrates that helps in the formation of blood clots. Human Fibrinogen is used as a medicine for blood disease. Human Fibrinogen is a preparation of coagulation factors prepared from pooled plasma. Currently, only RiaSTAP (CSL Behring) is licensed in a number of countries for multiple indications including treating acute bleeding episodes with Hypofibrinogenemia. Other manufacturer’s products are justly used in local region or countries.

Global Human Fibrinogen key players include CSL Behring, LFB Group, Shanghai RAAS Blood Products, Jiangxi Boya Bio-Pharmaceutical, GREEN CROSS, etc. Global top five manufacturers hold a share about 90%. Asia-Pacific is the largest consumption market, with a share about 60%, followed by Americas and Europe, total have a share over 30 percent. In terms of product, Human Fibrinogen Concentrate is the largest segment, with a share over 99%. And in terms of application, the largest application is Surgical Procedures.

This report is a detailed and comprehensive analysis for global Human Fibrinogen market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.

Key Features:

Global Human Fibrinogen market size and forecasts, in consumption value ($ Million), sales quantity (Kg), and average selling prices (USD/Kg), 2018-2029
Global Human Fibrinogen market size and forecasts by region and country, in consumption value ($ Million), sales quantity (Kg), and average selling prices (USD/Kg), 2018-2029
Global Human Fibrinogen market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (Kg), and average selling prices (USD/Kg), 2018-2029
Global Human Fibrinogen market shares of main players, shipments in revenue ($ Million), sales quantity (Kg), and ASP (USD/Kg), 2018-2023

The Primary Objectives in This Report Are:

To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Human Fibrinogen
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace

This report profiles key players in the global Human Fibrinogen market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.

   CSL Behring
   LFB Group
   Shanghai RAAS Blood Products
   Jiangxi Boya Bio-Pharmaceutical
   Hualan Biological Engineering
   Harbin Pacific Biopharmaceutical
   GREEN CROSS
   Shanghai XinXing Medical
   Octapharma

   Human Fibrinogen Concentrate
   Animal Fibrinogen Concentrate

   Congenital Fibrinogen Deficiency
   Surgical Procedures

   North America (United States, Canada and Mexico)
   Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
   Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
   South America (Brazil, Argentina, Colombia, and Rest of South America)
   Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)

What are the strengths of the Human Fibrinogen Market in 2025?

The Human Fibrinogen Market in 2025 benefits from the increasing prevalence of bleeding disorders and surgical procedures requiring fibrinogen supplementation. Additionally, advancements in manufacturing processes and increased awareness of fibrinogen's therapeutic applications contribute to market growth.

What are the weaknesses of the Human Fibrinogen Market in 2025?

One significant weakness is the limited availability of human-derived fibrinogen, which can lead to supply constraints. Furthermore, high production costs and regulatory challenges may hinder market expansion and accessibility for smaller manufacturers.

What opportunities exist in the Human Fibrinogen Market in 2025?

There are numerous opportunities, such as the development of new fibrinogen-based therapies and the expansion into emerging markets. Collaborations between research institutions and pharmaceutical companies can also drive innovation and enhance product offerings.

What threats could impact the Human Fibrinogen Market in 2025?

Threats include the potential for product recalls due to safety concerns, increased competition from alternative therapies, and stringent regulatory environments that may affect product approval timelines. Economic fluctuations could also influence healthcare budgets, impacting the market's growth.

What political factors influence the Human Fibrinogen Market in 2025?

Government regulations on blood plasma-derived products and stringent approval processes impact market dynamics. Policies related to healthcare funding and trade agreements also influence the availability and pricing of fibrinogen products.

What economic factors affect the Human Fibrinogen Market in 2025?

Global economic conditions determine healthcare budgets and patient access to fibrinogen treatments. High production costs and reimbursement policies play a crucial role in market expansion and affordability.

What social factors shape the Human Fibrinogen Market in 2025?

Rising awareness of bleeding disorders and the growing elderly population drive demand for fibrinogen therapies. Additionally, patient advocacy groups and improved diagnostic rates contribute to market growth.

What technological factors impact the Human Fibrinogen Market in 2025?

Advancements in biopharmaceutical manufacturing, improved plasma fractionation techniques, and recombinant fibrinogen development enhance product quality and availability. Innovations in drug delivery methods also create new market opportunities.

What environmental factors affect the Human Fibrinogen Market in 2025?

Sustainability concerns related to plasma collection and ethical sourcing of human blood products are key challenges. Regulatory pressure to adopt environmentally friendly production processes is also increasing.

What legal factors influence the Human Fibrinogen Market in 2025?

Strict regulatory frameworks for plasma-derived therapies, intellectual property rights, and compliance with Good Manufacturing Practices (GMP) shape market operations. Legal challenges related to pricing and patient access remain areas of concern.

Who are the key suppliers in the Human Fibrinogen Market in 2025?

Major suppliers include blood plasma collection centers, biopharmaceutical companies, and specialized contract manufacturers. Research institutions and technology providers also play a crucial role in ensuring product development and innovation.

What are the key inputs in the Human Fibrinogen Market in 2025?

Essential inputs include human plasma, purification reagents, advanced bioprocessing equipment, and regulatory compliance frameworks. Skilled professionals and research funding are also vital for maintaining production efficiency.

What are the main processes in the Human Fibrinogen Market in 2025?

Key processes involve plasma collection, fibrinogen extraction, purification, quality testing, packaging, and regulatory approval. Continuous process optimization ensures safety, efficacy, and scalability.

Who are the key outputs in the Human Fibrinogen Market in 2025?

The primary outputs include fibrinogen concentrate products for medical use, recombinant fibrinogen formulations, and diagnostic solutions. These products are critical for treating bleeding disorders, surgical bleeding, and trauma-related conditions.

Who are the key customers in the Human Fibrinogen Market in 2025?

Hospitals, surgical centers, blood banks, and research institutions form the primary customer base. Patients with congenital or acquired fibrinogen deficiencies, as well as trauma victims, rely on these treatments for survival and recovery.

How intense is the competitive rivalry in the Human Fibrinogen Market in 2025?

The market is highly competitive, with major pharmaceutical companies, plasma fractionation firms, and biotech startups striving for market share. Differentiation through innovation, pricing strategies, and regulatory approvals plays a key role in staying ahead.

What is the threat of new entrants in the Human Fibrinogen Market in 2025?

The threat is moderate due to high capital investment, stringent regulatory requirements, and the need for advanced manufacturing capabilities. However, breakthroughs in recombinant fibrinogen production may lower entry barriers for biotech firms.

How strong is the bargaining power of suppliers in the Human Fibrinogen Market in 2025?

Suppliers hold significant power as human plasma collection is a complex, regulated process with limited sources. Advanced purification technologies and proprietary extraction methods further strengthen supplier influence.

How strong is the bargaining power of buyers in the Human Fibrinogen Market in 2025?

Hospitals, healthcare providers, and government agencies exert moderate to high bargaining power, as they seek cost-effective and high-quality fibrinogen products. However, limited alternatives and the critical nature of the product reduce buyer influence.

What is the threat of substitutes in the Human Fibrinogen Market in 2025?

The threat is low to moderate, as few direct substitutes exist for human fibrinogen in treating bleeding disorders. However, synthetic hemostatic agents and alternative coagulation therapies are emerging, posing potential competition in specific cases.

What are the key upstream components in the Human Fibrinogen Market in 2025?

The upstream segment includes plasma collection centers, blood banks, and specialized suppliers of bioprocessing equipment and reagents. Research institutions also contribute by developing improved extraction and purification methods.

What role do plasma donors play in the upstream supply chain?

Plasma donors are essential, as human fibrinogen is derived from blood plasma. The availability of healthy donors, strict donor screening, and ethical collection practices directly impact supply stability and product quality.

What challenges affect the upstream supply chain in the Human Fibrinogen Market in 2025?

Challenges include donor shortages, regulatory restrictions on plasma collection, and high costs associated with maintaining compliance. Global supply chain disruptions and limited access to advanced purification technologies also create bottlenecks.

How do technological advancements influence the upstream segment?

Innovations in plasma fractionation, recombinant fibrinogen production, and automated bioprocessing systems enhance efficiency and yield. Improved cryopreservation and storage methods further stabilize supply availability.

How do regulatory policies impact upstream operations?

Strict guidelines govern plasma collection, donor eligibility, and purification standards to ensure safety and efficacy. Compliance with Good Manufacturing Practices (GMP) and evolving international regulations pose continuous operational challenges.

What are the key midstream processes in the Human Fibrinogen Market in 2025?

The midstream segment involves plasma fractionation, fibrinogen purification, quality control testing, and product formulation. These processes ensure that fibrinogen concentrates meet safety and efficacy standards before distribution.

What technologies are used in midstream processing?

Advanced chromatography, cryoprecipitation, and filtration techniques are used for fibrinogen extraction. Automation and AI-driven quality control systems help optimize efficiency and reduce contamination risks.

What challenges affect the midstream supply chain?

High production costs, stringent regulatory compliance, and batch-to-batch variability in plasma-derived products create challenges. Limited availability of skilled personnel and the need for specialized infrastructure further impact production.

How does regulatory oversight influence midstream operations?

Regulatory bodies impose strict guidelines on manufacturing, storage, and testing to ensure product safety. Compliance with Good Manufacturing Practices (GMP) and continuous audits require significant investment and process optimization.

How do midstream players add value to the Human Fibrinogen Market?

Manufacturers enhance product stability, improve purification yields, and develop innovative formulations such as recombinant fibrinogen. Strategic collaborations with research institutions and healthcare providers drive further advancements.

What are the key downstream components in the Human Fibrinogen Market in 2025?

The downstream segment includes distribution networks, hospitals, surgical centers, blood banks, and end-users such as patients with bleeding disorders or undergoing surgery. Pharmaceutical companies and healthcare providers play a vital role in product delivery.

How is human fibrinogen distributed to end-users?

Fibrinogen products are supplied through specialized distributors, hospital pharmacies, and direct procurement by healthcare institutions. Cold-chain logistics ensure product stability during transportation and storage.

What challenges impact the downstream supply chain?

Pricing pressures, reimbursement complexities, and regulatory approval delays affect market access. Limited awareness in certain regions and supply chain disruptions can also hinder timely product availability.

How do healthcare policies influence the downstream market?

Government policies on drug pricing, insurance coverage, and reimbursement rates shape patient access to fibrinogen therapy. Public healthcare funding and hospital procurement strategies directly impact demand.

What trends are shaping the downstream segment of the Human Fibrinogen Market?

Increasing adoption of recombinant fibrinogen, rising demand for personalized medicine, and integration of digital supply chain solutions are key trends. Expanding access in emerging markets also presents new growth opportunities.

Chapter 1, to describe Human Fibrinogen product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Human Fibrinogen, with price, sales, revenue and global market share of Human Fibrinogen from 2018 to 2023.
Chapter 3, the Human Fibrinogen competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Human Fibrinogen breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2018 to 2029.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2018 to 2029.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2022.and Human Fibrinogen market forecast, by regions, type and application, with sales and revenue, from 2024 to 2029.
Chapter 12, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War.
Chapter 13, the key raw materials and key suppliers, and industry chain of Human Fibrinogen.
Chapter 14 and 15, to describe Human Fibrinogen sales channel, distributors, customers, research findings and conclusion.

1 Market Overview

   1.1 Product Overview and Scope of Human Fibrinogen
   1.2 Market Estimation Caveats and Base Year
   1.3 Market Analysis by Type
       1.3.1 Overview: Global Human Fibrinogen Consumption Value by Type: 2018 Versus 2022 Versus 2029
       1.3.2 Human Fibrinogen Concentrate
       1.3.3 Animal Fibrinogen Concentrate
   1.4 Market Analysis by Application
       1.4.1 Overview: Global Human Fibrinogen Consumption Value by Application: 2018 Versus 2022 Versus 2029
       1.4.2 Congenital Fibrinogen Deficiency
       1.4.3 Surgical Procedures
   1.5 Global Human Fibrinogen Market Size & Forecast
       1.5.1 Global Human Fibrinogen Consumption Value (2018 & 2022 & 2029)
       1.5.2 Global Human Fibrinogen Sales Quantity (2018-2029)
       1.5.3 Global Human Fibrinogen Average Price (2018-2029)

2 Manufacturers Profiles

   2.1 CSL Behring
       2.1.1 CSL Behring Details
       2.1.2 CSL Behring Major Business
       2.1.3 CSL Behring Human Fibrinogen Product and Services
       2.1.4 CSL Behring Human Fibrinogen Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
       2.1.5 CSL Behring Recent Developments/Updates
   2.2 LFB Group
       2.2.1 LFB Group Details
       2.2.2 LFB Group Major Business
       2.2.3 LFB Group Human Fibrinogen Product and Services
       2.2.4 LFB Group Human Fibrinogen Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
       2.2.5 LFB Group Recent Developments/Updates
   2.3 Shanghai RAAS Blood Products
       2.3.1 Shanghai RAAS Blood Products Details
       2.3.2 Shanghai RAAS Blood Products Major Business
       2.3.3 Shanghai RAAS Blood Products Human Fibrinogen Product and Services
       2.3.4 Shanghai RAAS Blood Products Human Fibrinogen Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
       2.3.5 Shanghai RAAS Blood Products Recent Developments/Updates
   2.4 Jiangxi Boya Bio-Pharmaceutical
       2.4.1 Jiangxi Boya Bio-Pharmaceutical Details
       2.4.2 Jiangxi Boya Bio-Pharmaceutical Major Business
       2.4.3 Jiangxi Boya Bio-Pharmaceutical Human Fibrinogen Product and Services
       2.4.4 Jiangxi Boya Bio-Pharmaceutical Human Fibrinogen Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
       2.4.5 Jiangxi Boya Bio-Pharmaceutical Recent Developments/Updates
   2.5 Hualan Biological Engineering
       2.5.1 Hualan Biological Engineering Details
       2.5.2 Hualan Biological Engineering Major Business
       2.5.3 Hualan Biological Engineering Human Fibrinogen Product and Services
       2.5.4 Hualan Biological Engineering Human Fibrinogen Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
       2.5.5 Hualan Biological Engineering Recent Developments/Updates
   2.6 Harbin Pacific Biopharmaceutical
       2.6.1 Harbin Pacific Biopharmaceutical Details
       2.6.2 Harbin Pacific Biopharmaceutical Major Business
       2.6.3 Harbin Pacific Biopharmaceutical Human Fibrinogen Product and Services
       2.6.4 Harbin Pacific Biopharmaceutical Human Fibrinogen Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
       2.6.5 Harbin Pacific Biopharmaceutical Recent Developments/Updates
   2.7 GREEN CROSS
       2.7.1 GREEN CROSS Details
       2.7.2 GREEN CROSS Major Business
       2.7.3 GREEN CROSS Human Fibrinogen Product and Services
       2.7.4 GREEN CROSS Human Fibrinogen Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
       2.7.5 GREEN CROSS Recent Developments/Updates
   2.8 Shanghai XinXing Medical
       2.8.1 Shanghai XinXing Medical Details
       2.8.2 Shanghai XinXing Medical Major Business
       2.8.3 Shanghai XinXing Medical Human Fibrinogen Product and Services
       2.8.4 Shanghai XinXing Medical Human Fibrinogen Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
       2.8.5 Shanghai XinXing Medical Recent Developments/Updates
   2.9 Octapharma
       2.9.1 Octapharma Details
       2.9.2 Octapharma Major Business
       2.9.3 Octapharma Human Fibrinogen Product and Services
       2.9.4 Octapharma Human Fibrinogen Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
       2.9.5 Octapharma Recent Developments/Updates

3 Competitive Environment: Human Fibrinogen by Manufacturer

   3.1 Global Human Fibrinogen Sales Quantity by Manufacturer (2018-2023)
   3.2 Global Human Fibrinogen Revenue by Manufacturer (2018-2023)
   3.3 Global Human Fibrinogen Average Price by Manufacturer (2018-2023)
   3.4 Market Share Analysis (2022)
       3.4.1 Producer Shipments of Human Fibrinogen by Manufacturer Revenue ($MM) and Market Share (%): 2022
       3.4.2 Top 3 Human Fibrinogen Manufacturer Market Share in 2022
       3.4.2 Top 6 Human Fibrinogen Manufacturer Market Share in 2022
   3.5 Human Fibrinogen Market: Overall Company Footprint Analysis
       3.5.1 Human Fibrinogen Market: Region Footprint
       3.5.2 Human Fibrinogen Market: Company Product Type Footprint
       3.5.3 Human Fibrinogen Market: Company Product Application Footprint
   3.6 New Market Entrants and Barriers to Market Entry
   3.7 Mergers, Acquisition, Agreements, and Collaborations

4 Consumption Analysis by Region

   4.1 Global Human Fibrinogen Market Size by Region
       4.1.1 Global Human Fibrinogen Sales Quantity by Region (2018-2029)
       4.1.2 Global Human Fibrinogen Consumption Value by Region (2018-2029)
       4.1.3 Global Human Fibrinogen Average Price by Region (2018-2029)
   4.2 North America Human Fibrinogen Consumption Value (2018-2029)
   4.3 Europe Human Fibrinogen Consumption Value (2018-2029)
   4.4 Asia-Pacific Human Fibrinogen Consumption Value (2018-2029)
   4.5 South America Human Fibrinogen Consumption Value (2018-2029)
   4.6 Middle East and Africa Human Fibrinogen Consumption Value (2018-2029)

5 Market Segment by Type

   5.1 Global Human Fibrinogen Sales Quantity by Type (2018-2029)
   5.2 Global Human Fibrinogen Consumption Value by Type (2018-2029)
   5.3 Global Human Fibrinogen Average Price by Type (2018-2029)

6 Market Segment by Application

   6.1 Global Human Fibrinogen Sales Quantity by Application (2018-2029)
   6.2 Global Human Fibrinogen Consumption Value by Application (2018-2029)
   6.3 Global Human Fibrinogen Average Price by Application (2018-2029)

7 North America

   7.1 North America Human Fibrinogen Sales Quantity by Type (2018-2029)
   7.2 North America Human Fibrinogen Sales Quantity by Application (2018-2029)
   7.3 North America Human Fibrinogen Market Size by Country
       7.3.1 North America Human Fibrinogen Sales Quantity by Country (2018-2029)
       7.3.2 North America Human Fibrinogen Consumption Value by Country (2018-2029)
       7.3.3 United States Market Size and Forecast (2018-2029)
       7.3.4 Canada Market Size and Forecast (2018-2029)
       7.3.5 Mexico Market Size and Forecast (2018-2029)

8 Europe

   8.1 Europe Human Fibrinogen Sales Quantity by Type (2018-2029)
   8.2 Europe Human Fibrinogen Sales Quantity by Application (2018-2029)
   8.3 Europe Human Fibrinogen Market Size by Country
       8.3.1 Europe Human Fibrinogen Sales Quantity by Country (2018-2029)
       8.3.2 Europe Human Fibrinogen Consumption Value by Country (2018-2029)
       8.3.3 Germany Market Size and Forecast (2018-2029)
       8.3.4 France Market Size and Forecast (2018-2029)
       8.3.5 United Kingdom Market Size and Forecast (2018-2029)
       8.3.6 Russia Market Size and Forecast (2018-2029)
       8.3.7 Italy Market Size and Forecast (2018-2029)

9 Asia-Pacific

   9.1 Asia-Pacific Human Fibrinogen Sales Quantity by Type (2018-2029)
   9.2 Asia-Pacific Human Fibrinogen Sales Quantity by Application (2018-2029)
   9.3 Asia-Pacific Human Fibrinogen Market Size by Region
       9.3.1 Asia-Pacific Human Fibrinogen Sales Quantity by Region (2018-2029)
       9.3.2 Asia-Pacific Human Fibrinogen Consumption Value by Region (2018-2029)
       9.3.3 China Market Size and Forecast (2018-2029)
       9.3.4 Japan Market Size and Forecast (2018-2029)
       9.3.5 Korea Market Size and Forecast (2018-2029)
       9.3.6 India Market Size and Forecast (2018-2029)
       9.3.7 Southeast Asia Market Size and Forecast (2018-2029)
       9.3.8 Australia Market Size and Forecast (2018-2029)

10 South America

   10.1 South America Human Fibrinogen Sales Quantity by Type (2018-2029)
   10.2 South America Human Fibrinogen Sales Quantity by Application (2018-2029)
   10.3 South America Human Fibrinogen Market Size by Country
       10.3.1 South America Human Fibrinogen Sales Quantity by Country (2018-2029)
       10.3.2 South America Human Fibrinogen Consumption Value by Country (2018-2029)
       10.3.3 Brazil Market Size and Forecast (2018-2029)
       10.3.4 Argentina Market Size and Forecast (2018-2029)

11 Middle East & Africa

   11.1 Middle East & Africa Human Fibrinogen Sales Quantity by Type (2018-2029)
   11.2 Middle East & Africa Human Fibrinogen Sales Quantity by Application (2018-2029)
   11.3 Middle East & Africa Human Fibrinogen Market Size by Country
       11.3.1 Middle East & Africa Human Fibrinogen Sales Quantity by Country (2018-2029)
       11.3.2 Middle East & Africa Human Fibrinogen Consumption Value by Country (2018-2029)
       11.3.3 Turkey Market Size and Forecast (2018-2029)
       11.3.4 Egypt Market Size and Forecast (2018-2029)
       11.3.5 Saudi Arabia Market Size and Forecast (2018-2029)
       11.3.6 South Africa Market Size and Forecast (2018-2029)

12 Market Dynamics

   12.1 Human Fibrinogen Market Drivers
   12.2 Human Fibrinogen Market Restraints
   12.3 Human Fibrinogen Trends Analysis
   12.4 Porters Five Forces Analysis
       12.4.1 Threat of New Entrants
       12.4.2 Bargaining Power of Suppliers
       12.4.3 Bargaining Power of Buyers
       12.4.4 Threat of Substitutes
       12.4.5 Competitive Rivalry
   12.5 Influence of COVID-19 and Russia-Ukraine War
       12.5.1 Influence of COVID-19
       12.5.2 Influence of Russia-Ukraine War

13 Raw Material and Industry Chain

   13.1 Raw Material of Human Fibrinogen and Key Manufacturers
   13.2 Manufacturing Costs Percentage of Human Fibrinogen
   13.3 Human Fibrinogen Production Process
   13.4 Human Fibrinogen Industrial Chain

14 Shipments by Distribution Channel

   14.1 Sales Channel
       14.1.1 Direct to End-User
       14.1.2 Distributors
   14.2 Human Fibrinogen Typical Distributors
   14.3 Human Fibrinogen Typical Customers

15 Research Findings and Conclusion

16 Appendix

   16.1 Methodology
   16.2 Research Process and Data Source
   16.3 Disclaimer

List of Tables

   Table 1. Global Human Fibrinogen Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
   Table 2. Global Human Fibrinogen Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
   Table 3. CSL Behring Basic Information, Manufacturing Base and Competitors
   Table 4. CSL Behring Major Business
   Table 5. CSL Behring Human Fibrinogen Product and Services
   Table 6. CSL Behring Human Fibrinogen Sales Quantity (Kg), Average Price (USD/Kg), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
   Table 7. CSL Behring Recent Developments/Updates
   Table 8. LFB Group Basic Information, Manufacturing Base and Competitors
   Table 9. LFB Group Major Business
   Table 10. LFB Group Human Fibrinogen Product and Services
   Table 11. LFB Group Human Fibrinogen Sales Quantity (Kg), Average Price (USD/Kg), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
   Table 12. LFB Group Recent Developments/Updates
   Table 13. Shanghai RAAS Blood Products Basic Information, Manufacturing Base and Competitors
   Table 14. Shanghai RAAS Blood Products Major Business
   Table 15. Shanghai RAAS Blood Products Human Fibrinogen Product and Services
   Table 16. Shanghai RAAS Blood Products Human Fibrinogen Sales Quantity (Kg), Average Price (USD/Kg), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
   Table 17. Shanghai RAAS Blood Products Recent Developments/Updates
   Table 18. Jiangxi Boya Bio-Pharmaceutical Basic Information, Manufacturing Base and Competitors
   Table 19. Jiangxi Boya Bio-Pharmaceutical Major Business
   Table 20. Jiangxi Boya Bio-Pharmaceutical Human Fibrinogen Product and Services
   Table 21. Jiangxi Boya Bio-Pharmaceutical Human Fibrinogen Sales Quantity (Kg), Average Price (USD/Kg), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
   Table 22. Jiangxi Boya Bio-Pharmaceutical Recent Developments/Updates
   Table 23. Hualan Biological Engineering Basic Information, Manufacturing Base and Competitors
   Table 24. Hualan Biological Engineering Major Business
   Table 25. Hualan Biological Engineering Human Fibrinogen Product and Services
   Table 26. Hualan Biological Engineering Human Fibrinogen Sales Quantity (Kg), Average Price (USD/Kg), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
   Table 27. Hualan Biological Engineering Recent Developments/Updates
   Table 28. Harbin Pacific Biopharmaceutical Basic Information, Manufacturing Base and Competitors
   Table 29. Harbin Pacific Biopharmaceutical Major Business
   Table 30. Harbin Pacific Biopharmaceutical Human Fibrinogen Product and Services
   Table 31. Harbin Pacific Biopharmaceutical Human Fibrinogen Sales Quantity (Kg), Average Price (USD/Kg), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
   Table 32. Harbin Pacific Biopharmaceutical Recent Developments/Updates
   Table 33. GREEN CROSS Basic Information, Manufacturing Base and Competitors
   Table 34. GREEN CROSS Major Business
   Table 35. GREEN CROSS Human Fibrinogen Product and Services
   Table 36. GREEN CROSS Human Fibrinogen Sales Quantity (Kg), Average Price (USD/Kg), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
   Table 37. GREEN CROSS Recent Developments/Updates
   Table 38. Shanghai XinXing Medical Basic Information, Manufacturing Base and Competitors
   Table 39. Shanghai XinXing Medical Major Business
   Table 40. Shanghai XinXing Medical Human Fibrinogen Product and Services
   Table 41. Shanghai XinXing Medical Human Fibrinogen Sales Quantity (Kg), Average Price (USD/Kg), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
   Table 42. Shanghai XinXing Medical Recent Developments/Updates
   Table 43. Octapharma Basic Information, Manufacturing Base and Competitors
   Table 44. Octapharma Major Business
   Table 45. Octapharma Human Fibrinogen Product and Services
   Table 46. Octapharma Human Fibrinogen Sales Quantity (Kg), Average Price (USD/Kg), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
   Table 47. Octapharma Recent Developments/Updates
   Table 48. Global Human Fibrinogen Sales Quantity by Manufacturer (2018-2023) & (Kg)
   Table 49. Global Human Fibrinogen Revenue by Manufacturer (2018-2023) & (USD Million)
   Table 50. Global Human Fibrinogen Average Price by Manufacturer (2018-2023) & (USD/Kg)
   Table 51. Market Position of Manufacturers in Human Fibrinogen, (Tier 1, Tier 2, and Tier 3), Based on Consumption Value in 2022
   Table 52. Head Office and Human Fibrinogen Production Site of Key Manufacturer
   Table 53. Human Fibrinogen Market: Company Product Type Footprint
   Table 54. Human Fibrinogen Market: Company Product Application Footprint
   Table 55. Human Fibrinogen New Market Entrants and Barriers to Market Entry
   Table 56. Human Fibrinogen Mergers, Acquisition, Agreements, and Collaborations
   Table 57. Global Human Fibrinogen Sales Quantity by Region (2018-2023) & (Kg)
   Table 58. Global Human Fibrinogen Sales Quantity by Region (2024-2029) & (Kg)
   Table 59. Global Human Fibrinogen Consumption Value by Region (2018-2023) & (USD Million)
   Table 60. Global Human Fibrinogen Consumption Value by Region (2024-2029) & (USD Million)
   Table 61. Global Human Fibrinogen Average Price by Region (2018-2023) & (USD/Kg)
   Table 62. Global Human Fibrinogen Average Price by Region (2024-2029) & (USD/Kg)
   Table 63. Global Human Fibrinogen Sales Quantity by Type (2018-2023) & (Kg)
   Table 64. Global Human Fibrinogen Sales Quantity by Type (2024-2029) & (Kg)
   Table 65. Global Human Fibrinogen Consumption Value by Type (2018-2023) & (USD Million)
   Table 66. Global Human Fibrinogen Consumption Value by Type (2024-2029) & (USD Million)
   Table 67. Global Human Fibrinogen Average Price by Type (2018-2023) & (USD/Kg)
   Table 68. Global Human Fibrinogen Average Price by Type (2024-2029) & (USD/Kg)
   Table 69. Global Human Fibrinogen Sales Quantity by Application (2018-2023) & (Kg)
   Table 70. Global Human Fibrinogen Sales Quantity by Application (2024-2029) & (Kg)
   Table 71. Global Human Fibrinogen Consumption Value by Application (2018-2023) & (USD Million)
   Table 72. Global Human Fibrinogen Consumption Value by Application (2024-2029) & (USD Million)
   Table 73. Global Human Fibrinogen Average Price by Application (2018-2023) & (USD/Kg)
   Table 74. Global Human Fibrinogen Average Price by Application (2024-2029) & (USD/Kg)
   Table 75. North America Human Fibrinogen Sales Quantity by Type (2018-2023) & (Kg)
   Table 76. North America Human Fibrinogen Sales Quantity by Type (2024-2029) & (Kg)
   Table 77. North America Human Fibrinogen Sales Quantity by Application (2018-2023) & (Kg)
   Table 78. North America Human Fibrinogen Sales Quantity by Application (2024-2029) & (Kg)
   Table 79. North America Human Fibrinogen Sales Quantity by Country (2018-2023) & (Kg)
   Table 80. North America Human Fibrinogen Sales Quantity by Country (2024-2029) & (Kg)
   Table 81. North America Human Fibrinogen Consumption Value by Country (2018-2023) & (USD Million)
   Table 82. North America Human Fibrinogen Consumption Value by Country (2024-2029) & (USD Million)
   Table 83. Europe Human Fibrinogen Sales Quantity by Type (2018-2023) & (Kg)
   Table 84. Europe Human Fibrinogen Sales Quantity by Type (2024-2029) & (Kg)
   Table 85. Europe Human Fibrinogen Sales Quantity by Application (2018-2023) & (Kg)
   Table 86. Europe Human Fibrinogen Sales Quantity by Application (2024-2029) & (Kg)
   Table 87. Europe Human Fibrinogen Sales Quantity by Country (2018-2023) & (Kg)
   Table 88. Europe Human Fibrinogen Sales Quantity by Country (2024-2029) & (Kg)
   Table 89. Europe Human Fibrinogen Consumption Value by Country (2018-2023) & (USD Million)
   Table 90. Europe Human Fibrinogen Consumption Value by Country (2024-2029) & (USD Million)
   Table 91. Asia-Pacific Human Fibrinogen Sales Quantity by Type (2018-2023) & (Kg)
   Table 92. Asia-Pacific Human Fibrinogen Sales Quantity by Type (2024-2029) & (Kg)
   Table 93. Asia-Pacific Human Fibrinogen Sales Quantity by Application (2018-2023) & (Kg)
   Table 94. Asia-Pacific Human Fibrinogen Sales Quantity by Application (2024-2029) & (Kg)
   Table 95. Asia-Pacific Human Fibrinogen Sales Quantity by Region (2018-2023) & (Kg)
   Table 96. Asia-Pacific Human Fibrinogen Sales Quantity by Region (2024-2029) & (Kg)
   Table 97. Asia-Pacific Human Fibrinogen Consumption Value by Region (2018-2023) & (USD Million)
   Table 98. Asia-Pacific Human Fibrinogen Consumption Value by Region (2024-2029) & (USD Million)
   Table 99. South America Human Fibrinogen Sales Quantity by Type (2018-2023) & (Kg)
   Table 100. South America Human Fibrinogen Sales Quantity by Type (2024-2029) & (Kg)
   Table 101. South America Human Fibrinogen Sales Quantity by Application (2018-2023) & (Kg)
   Table 102. South America Human Fibrinogen Sales Quantity by Application (2024-2029) & (Kg)
   Table 103. South America Human Fibrinogen Sales Quantity by Country (2018-2023) & (Kg)
   Table 104. South America Human Fibrinogen Sales Quantity by Country (2024-2029) & (Kg)
   Table 105. South America Human Fibrinogen Consumption Value by Country (2018-2023) & (USD Million)
   Table 106. South America Human Fibrinogen Consumption Value by Country (2024-2029) & (USD Million)
   Table 107. Middle East & Africa Human Fibrinogen Sales Quantity by Type (2018-2023) & (Kg)
   Table 108. Middle East & Africa Human Fibrinogen Sales Quantity by Type (2024-2029) & (Kg)
   Table 109. Middle East & Africa Human Fibrinogen Sales Quantity by Application (2018-2023) & (Kg)
   Table 110. Middle East & Africa Human Fibrinogen Sales Quantity by Application (2024-2029) & (Kg)
   Table 111. Middle East & Africa Human Fibrinogen Sales Quantity by Region (2018-2023) & (Kg)
   Table 112. Middle East & Africa Human Fibrinogen Sales Quantity by Region (2024-2029) & (Kg)
   Table 113. Middle East & Africa Human Fibrinogen Consumption Value by Region (2018-2023) & (USD Million)
   Table 114. Middle East & Africa Human Fibrinogen Consumption Value by Region (2024-2029) & (USD Million)
   Table 115. Human Fibrinogen Raw Material
   Table 116. Key Manufacturers of Human Fibrinogen Raw Materials
   Table 117. Human Fibrinogen Typical Distributors
   Table 118. Human Fibrinogen Typical Customers

List of Figures

   Figure 1. Human Fibrinogen Picture
   Figure 2. Global Human Fibrinogen Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
   Figure 3. Global Human Fibrinogen Consumption Value Market Share by Type in 2022
   Figure 4. Human Fibrinogen Concentrate Examples
   Figure 5. Animal Fibrinogen Concentrate Examples
   Figure 6. Global Human Fibrinogen Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
   Figure 7. Global Human Fibrinogen Consumption Value Market Share by Application in 2022
   Figure 8. Congenital Fibrinogen Deficiency Examples
   Figure 9. Surgical Procedures Examples
   Figure 10. Global Human Fibrinogen Consumption Value, (USD Million): 2018 & 2022 & 2029
   Figure 11. Global Human Fibrinogen Consumption Value and Forecast (2018-2029) & (USD Million)
   Figure 12. Global Human Fibrinogen Sales Quantity (2018-2029) & (Kg)
   Figure 13. Global Human Fibrinogen Average Price (2018-2029) & (USD/Kg)
   Figure 14. Global Human Fibrinogen Sales Quantity Market Share by Manufacturer in 2022
   Figure 15. Global Human Fibrinogen Consumption Value Market Share by Manufacturer in 2022
   Figure 16. Producer Shipments of Human Fibrinogen by Manufacturer Sales Quantity ($MM) and Market Share (%): 2021
   Figure 17. Top 3 Human Fibrinogen Manufacturer (Consumption Value) Market Share in 2022
   Figure 18. Top 6 Human Fibrinogen Manufacturer (Consumption Value) Market Share in 2022
   Figure 19. Global Human Fibrinogen Sales Quantity Market Share by Region (2018-2029)
   Figure 20. Global Human Fibrinogen Consumption Value Market Share by Region (2018-2029)
   Figure 21. North America Human Fibrinogen Consumption Value (2018-2029) & (USD Million)
   Figure 22. Europe Human Fibrinogen Consumption Value (2018-2029) & (USD Million)
   Figure 23. Asia-Pacific Human Fibrinogen Consumption Value (2018-2029) & (USD Million)
   Figure 24. South America Human Fibrinogen Consumption Value (2018-2029) & (USD Million)
   Figure 25. Middle East & Africa Human Fibrinogen Consumption Value (2018-2029) & (USD Million)
   Figure 26. Global Human Fibrinogen Sales Quantity Market Share by Type (2018-2029)
   Figure 27. Global Human Fibrinogen Consumption Value Market Share by Type (2018-2029)
   Figure 28. Global Human Fibrinogen Average Price by Type (2018-2029) & (USD/Kg)
   Figure 29. Global Human Fibrinogen Sales Quantity Market Share by Application (2018-2029)
   Figure 30. Global Human Fibrinogen Consumption Value Market Share by Application (2018-2029)
   Figure 31. Global Human Fibrinogen Average Price by Application (2018-2029) & (USD/Kg)
   Figure 32. North America Human Fibrinogen Sales Quantity Market Share by Type (2018-2029)
   Figure 33. North America Human Fibrinogen Sales Quantity Market Share by Application (2018-2029)
   Figure 34. North America Human Fibrinogen Sales Quantity Market Share by Country (2018-2029)
   Figure 35. North America Human Fibrinogen Consumption Value Market Share by Country (2018-2029)
   Figure 36. United States Human Fibrinogen Consumption Value and Growth Rate (2018-2029) & (USD Million)
   Figure 37. Canada Human Fibrinogen Consumption Value and Growth Rate (2018-2029) & (USD Million)
   Figure 38. Mexico Human Fibrinogen Consumption Value and Growth Rate (2018-2029) & (USD Million)
   Figure 39. Europe Human Fibrinogen Sales Quantity Market Share by Type (2018-2029)
   Figure 40. Europe Human Fibrinogen Sales Quantity Market Share by Application (2018-2029)
   Figure 41. Europe Human Fibrinogen Sales Quantity Market Share by Country (2018-2029)
   Figure 42. Europe Human Fibrinogen Consumption Value Market Share by Country (2018-2029)
   Figure 43. Germany Human Fibrinogen Consumption Value and Growth Rate (2018-2029) & (USD Million)
   Figure 44. France Human Fibrinogen Consumption Value and Growth Rate (2018-2029) & (USD Million)
   Figure 45. United Kingdom Human Fibrinogen Consumption Value and Growth Rate (2018-2029) & (USD Million)
   Figure 46. Russia Human Fibrinogen Consumption Value and Growth Rate (2018-2029) & (USD Million)
   Figure 47. Italy Human Fibrinogen Consumption Value and Growth Rate (2018-2029) & (USD Million)
   Figure 48. Asia-Pacific Human Fibrinogen Sales Quantity Market Share by Type (2018-2029)
   Figure 49. Asia-Pacific Human Fibrinogen Sales Quantity Market Share by Application (2018-2029)
   Figure 50. Asia-Pacific Human Fibrinogen Sales Quantity Market Share by Region (2018-2029)
   Figure 51. Asia-Pacific Human Fibrinogen Consumption Value Market Share by Region (2018-2029)
   Figure 52. China Human Fibrinogen Consumption Value and Growth Rate (2018-2029) & (USD Million)
   Figure 53. Japan Human Fibrinogen Consumption Value and Growth Rate (2018-2029) & (USD Million)
   Figure 54. Korea Human Fibrinogen Consumption Value and Growth Rate (2018-2029) & (USD Million)
   Figure 55. India Human Fibrinogen Consumption Value and Growth Rate (2018-2029) & (USD Million)
   Figure 56. Southeast Asia Human Fibrinogen Consumption Value and Growth Rate (2018-2029) & (USD Million)
   Figure 57. Australia Human Fibrinogen Consumption Value and Growth Rate (2018-2029) & (USD Million)
   Figure 58. South America Human Fibrinogen Sales Quantity Market Share by Type (2018-2029)
   Figure 59. South America Human Fibrinogen Sales Quantity Market Share by Application (2018-2029)
   Figure 60. South America Human Fibrinogen Sales Quantity Market Share by Country (2018-2029)
   Figure 61. South America Human Fibrinogen Consumption Value Market Share by Country (2018-2029)
   Figure 62. Brazil Human Fibrinogen Consumption Value and Growth Rate (2018-2029) & (USD Million)
   Figure 63. Argentina Human Fibrinogen Consumption Value and Growth Rate (2018-2029) & (USD Million)
   Figure 64. Middle East & Africa Human Fibrinogen Sales Quantity Market Share by Type (2018-2029)
   Figure 65. Middle East & Africa Human Fibrinogen Sales Quantity Market Share by Application (2018-2029)
   Figure 66. Middle East & Africa Human Fibrinogen Sales Quantity Market Share by Region (2018-2029)
   Figure 67. Middle East & Africa Human Fibrinogen Consumption Value Market Share by Region (2018-2029)
   Figure 68. Turkey Human Fibrinogen Consumption Value and Growth Rate (2018-2029) & (USD Million)
   Figure 69. Egypt Human Fibrinogen Consumption Value and Growth Rate (2018-2029) & (USD Million)
   Figure 70. Saudi Arabia Human Fibrinogen Consumption Value and Growth Rate (2018-2029) & (USD Million)
   Figure 71. South Africa Human Fibrinogen Consumption Value and Growth Rate (2018-2029) & (USD Million)
   Figure 72. Human Fibrinogen Market Drivers
   Figure 73. Human Fibrinogen Market Restraints
   Figure 74. Human Fibrinogen Market Trends
   Figure 75. Porters Five Forces Analysis
   Figure 76. Manufacturing Cost Structure Analysis of Human Fibrinogen in 2022
   Figure 77. Manufacturing Process Analysis of Human Fibrinogen
   Figure 78. Human Fibrinogen Industrial Chain
   Figure 79. Sales Quantity Channel: Direct to End-User vs Distributors
   Figure 80. Direct Channel Pros & Cons
   Figure 81. Indirect Channel Pros & Cons
   Figure 82. Methodology
   Figure 83. Research Process and Data Source